Pamela Rungqu

Dr. Pamela Rungqu


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
LMLihle Mdleleni
Lihle Mdleleni
PRPamela Rungqu
Pamela Rungqu
Tobeka NakiTobeka Naki
Tobeka Naki
Triterpenoids are a diverse class of naturally occurring compounds with a wide range of pharmacological properties, including anticancer, anti-inflammatory, antimicrobial, and antiviral activities. Among them, ursolic acid (UA), oleanolic acid (OA), and betulinic acid (BA) have emerged as key scaffolds due to their broad therapeutic potential and structural versatility. However, the clinical application of these compounds is often limited by issues such as poor solubility, bioavailability, and selectivity. To address these challenges, research conducted between 2015 and 2025 increasingly focused on the development of triterpenoid-based hybrid molecules, in which the triterpenoid scaffolds are chemically linked to other bioactive pharmacophores. This approach aims to enhance therapeutic efficacy through synergistic action, improved pharmacokinetics, and multitarget interactions. This comprehensive review explores recent advancements in the design, synthesis, and evaluation of hybrid derivatives of selected triterpenoids, particularly UA, OA, and BA. Emphasis is placed on the structure–activity relationships (SARs), biological evaluations, and mechanisms of action of these hybrid compounds across various disease models. The review also highlights current challenges, research gaps, and future perspectives in the rational development of triterpenoid-based hybrids as potential leading candidates in drug discovery.

10 August 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Sinovuyo MtendwaSinovuyo Mtendwa
Sinovuyo Mtendwa
PRPamela Rungqu
Pamela Rungqu
VMVuyani Maqanda
Vuyani Maqanda
This review consolidates current knowledge on the phytochemical composition, traditional uses, pharmacological properties, and industrial application of Ricinus communis L. This plant belongs to the Euphorbiaceae family and is a globally distributed plant of considerable medicinal and industrial importance. It is rich in bioactive compounds, notably ricinoleic acid as the dominant fatty acid in seed oil, as well as ricin, ricinine, phenolic acids and flavonoids distributed across different plant parts. Variations in phytochemical profiles among cultivars and tissues are influenced by genetic and environmental influences. Traditional medicinal uses of the leaves, roots, seeds, and oil, particularly for inflammatory conditions, pain, infections, wound healing, and gastrointestinal disorders, are critically examined in relation to experimental pharmacological evidence. Castor oil extracted from the R. communis plant remains central to the plant’s industrial value, serving as a renewable feedstock for pharmaceuticals, cosmetics, polymers, lubricants, and biofuels due to the unique hydroxyl functionality of ricinoleic acid. However, the presence of the highly toxic protein ricin in unprocessed seeds necessitates strict processing and safety controls. Overall, R. communis emerges as a chemically versatile species with significant therapeutic and industrial potential, warranting further research into cultivar-specific chemistry, standardization of extraction and testing methods, and safe value-adding applications.

9 June 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Sinovuyo MtendwaSinovuyo Mtendwa
Sinovuyo Mtendwa
PRPamela Rungqu
Pamela Rungqu
VMVuyani Maqanda
Vuyani Maqanda
This review consolidates current knowledge on the phytochemical composition, traditional uses, pharmacological properties, and industrial application of Ricinus communis L. This plant belongs to the Euphorbiaceae family and is a globally distributed plant of considerable medicinal and industrial importance. It is rich in bioactive compounds, notably ricinoleic acid as the dominant fatty acid in seed oil, as well as ricin, ricinine, phenolic acids and flavonoids distributed across different plant parts. Variations in phytochemical profiles among cultivars and tissues are influenced by genetic and environmental influences. Traditional medicinal uses of the leaves, roots, seeds, and oil particularly for inflammatory conditions, pain, infections, wound healing, and gastrointestinal disorders are critically examined in relation to experimental pharmacological evidence. Castor oil extracted from the R. communis plant remains central to the plant’s industrial value, serving as a renewable feedstock for pharmaceuticals, cosmetics, polymers, lubricants, and biofuels due to the unique hydroxyl functionality of ricinoleic acid. However, the presence of the highly toxic protein ricin in unprocessed seeds necessitates strict processing and safety controls. Overall, R. communis emerges as a chemically versatile species with significant therapeutic and industrial potential, warranting further research into cultivar-specific chemistry, standardisation of extraction and testing methods, and safe value-adding applications.